baber/WOPTO huggingface dataset:
Patent NZ-273865-A (NZ)
Title: Obtaining high purity ig from antibody rich colostrum and compositions thereof
Inventor: GRAHAM CONOR JOHN
IPC: C07K1/30
Filed: 1994-09-20
Abstract: PCT No. PCT/AU94/00562 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed Sep. 20, 1994 PCT Pub. No. WO95/08562 PCT Pub. Date Mar. 30, 1995A pharmaceutical composition consisting, of nontoxic components wherein the nontoxic components comprise a core element comprising an antibody which binds to an antigen wherein the core element is a compressed tablet wherein compression forces used to prepare the tablet range from about 0.1 tonnes/cm2 to about 42.1 tonnes/cm2 and the process for preparing the composition.
Patent NZ-287696-A (NZ)
Title: Histidine or homohistidine derivatives; used as inhibitors of protein farnesyltransferase
Inventor: BOLTON GARY LOUIS
IPC: A61P43/00
Filed: 1995-05-30
Abstract: Novel inhibitors of protein farnesyltransferase enzyme are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in controlling tissue proliferative diseases, including cancer and restenosis.
Patent NZ-318434-A (NZ)
Title: Naphthamide derivatives of 3 beta-amino azabicyclo octane or nonane as neuroleptic or antipsychotic agents
Inventor: IMBERT THIERRY
IPC: A61P25/18
Filed: 1996-09-11
Abstract: PCT No. PCT/FR96/01394 Sec. 371 Date Mar. 12, 1998 Sec. 102(e) Date Mar. 12, 1998 PCT Filed Sep. 11, 1996 PCT Pub. No. WO97/10244 PCT Pub. Date Mar. 20, 1997The invention pertains to novel azabicyclo-naphthalene-carboxamide derivatives, a method for preparing same and the use thereof as a medicament. The compounds of the invention are of formula (I).
Patent NZ-505045-A (NZ)
Title: GnRH-leukotoxin chimeras
Inventor: POTTER ANDREW A
IPC: A61K38/09
Filed: 1997-08-08
Abstract: Described are vaccine compositions comprising a chimeric protein with a leukotoxin polypeptide fused to first and second multimers.  The C-terminus of the first multimer is fused to the N-terminus of the leukotoxin polypeptide and the N-terminus of the second multimer is fused to the C-terminus of the leukotoxin polypeptide.  Each of the multimers comprises more than one selected GnRH polypeptide which is the same or different.  The compositions may be used for presenting selected GnRH multimers to a patient for reducing the incidence of mammary tumors.
Patent NZ-505332-A (NZ)
Title: Using PAI-2 and t-PA as diagnostic markers of periodontal disease
Inventor: XIAO YIN
IPC: G01N33/53
Filed: 1999-01-26
Abstract: A method of diagnosing periodontal disease, comprises: a) determining the level of a protein in individual gingival crevicular fluid (GCF) samples, each sample being obtained from one of various sites of a patient, wherein the protein is selected from the group consisting of:  i) tissue-type plasminogen activator (t-PA) and ii) plasminogen activator inhibitor-2 (PAI-2) and b) obtaining the mean level of the protein in the GCF and using the mean level to diagnose periodontal disease whereby periodontitis is distinguished from gingivitis. The GCF is collected locally from two or more sites of the patient selected from the mesial sites, the buccal and labial sites on the lower teeth.  The level of the compound is determined using an enzyme-linked immunosorbent assay. Step b) can further include comparing the mean level of the protein in the GCF from the patient with a predetermined mean level of the protein in the GCF from a healthy individual.  A statistically significant increase of the mean level of the protein in the GCF indicates the presence of periodontal disease.
Patent NZ-505488-A (NZ)
Title: High speed log ladder
Inventor: REDEKOP STANLEY W
IPC: B65G25/08
Filed: 1997-11-28
Abstract: An  ending apparatus for a log ladder wherein the  log ladder  sorts, feeds and sequentially indexes logs  along  a longitudinal  array of laterally extending log cradles  that have   selectively  actuable  rollers  that  are   generally hourglass-shaped,  as a means of laterally  translating  the logs.  The rollers are coupled with sensing means to trigger selective  rotation of the rollers so as  to  allow  delayed triggering  of  the  lifting  and  culling  means,   thereby increasing  dwell  time of the logs on the  log  translating means.
Patent NZ-507170-A (NZ)
Title: Pressure/force computer controlled drug delivery system
Inventor: HOCHMAN MARK
IPC: A61M5/168
Filed: 1999-03-05
Abstract: An automatic injection device 10 includes a drive mechanism and a sensor used to determine an internal characteristic such as a force or internal pressure generated during an injection process. This characteristic is then used as a control parameter by a microprocessor or controller 18, which generates corresponding commands to the drive mechanism 12. In a particularly advantageous embodiment the characteristic is used to calculate an exit pressure at which fluid ejected by the device through an elongated tube 14. The drive mechanism 12 is then operated in such a manner that the exit pressure is maintained at a predetermined level to insure that a patient does not suffer pain and/or tissue damage.
Patent NZ-507284-A (NZ)
Title: Patch bag with patch containing polypropylene for food packaging
Inventor: RAMESH RAM KUMAR
IPC: B32B27/32
Filed: 2000-10-02
Abstract: A patch bag has a heat shrinkable patch film adhered to a heat-shrinkable bag film. The patch film contains at least one member selected from the group consisting of propylene homopolymer and propylene copolymer. The film used as the patch is preferably irradiated during its production. This polymer, in a patch film of a patch bag, can be selected to provide especially high elasticity and low crystallinity, thereby providing good impact strength, ease of processing (i.e. good orientation), high free shrink at 85oC.
Patent NZ-509177-A (NZ)
Title: Use of azabicyclic compounds for treating psychosis and neuropsychiatric symptoms in patients with alzheimerÆs disease
Inventor: CEDAR EVE NAOMI
IPC: A61P25/28
Filed: 1999-07-15
Abstract: The use of [R-(Z)]-ß-(methoxyimino)-ß-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of psychosis or other neuropsychiatric symptoms in patients with AlzheimerÆs Disease with severe behavioural disturbance.
Patent NZ-509341-A (NZ)
Title: Optical display with at least one optical coupler joining laminated optical panels at an optical transparent seam
Inventor: VELIGDAN JAMES T
IPC: G02B6/04
Filed: 1999-07-14
Abstract: The   present  invention  relates  to   an   improved transportation system which includes a plurality of  upright supports  which elevate at least one track (2). A  plurality of  cabs  (3) are adapted to move along the track or  tracks (2)  provided where the cabs (3) suspended from a track  (2) so  that the centre of mass of the cabs (3) is located below the  track (2). A single track (2) provides a pair  of  rail elements on opposite sides of the track (2) where the  first rail  element  is  adapted to support  cabs  (3)  moving  in substantially  the opposite direction to cabs (3)  supported by the second rail element of the same track (2).
Patent NZ-511271-A (NZ)
Title: Framed flat acoustic masking radiator for ceiling panel
Inventor: BISCHEL WESLEY T K
IPC: H04R9/00
Filed: 2001-04-23
Abstract: The flat panel radiator (200) is to be mounted into a ceiling grid (600). The ceiling grid (600) system includes openings defined by main beams and crossbeams. The main beams are secured through hanger wires to a hard ceiling. The main beams and crossbeams have flanges with the crossbeams resting on the flanges of the main beams. The mounting apparatus has a frame (210) including a top plate, side plate and bottom plate, containment elements (212) and isolation elements (214) attached to the frame (210) and an acoustically transparent scrim attached to the bottom of the frame (210). The flat panel radiator has electronic components (610) that induce vibrations on the panel using a driver (612). The flat panel radiator (200) is mounted between containment elements (212) and isolation elements (214). The radiator panel can be fabricated from a honeycomb core. The containment elements (212) may be made from a stiff to resilient material, whereas the isolation element (214) will always be resilient to vibrations to isolate the vibrations of the flat panel radiator (200) from the beams of the ceiling grid (600) both mechanically and acoustically. The flat panel sound radiator (200) can also be installed in wall partitions.
Patent NZ-511305-A (NZ)
Title: A process for the preparation of suspensions of drug particles for inhalation delivery
Inventor: BERNINI EVA
IPC: A61P11/00
Filed: 1999-10-28
Abstract: A process for the preparation of an aerosol inhalable suspension of particles is disclosed, wherein the process comprises: a) preparing a suspension of a steroid active ingredient, in a turboemulsifier provided with a turbine adapted for homogenising the suspension; b) optionally subjecting the resulting suspension to a further treatment in a high pressure homogeniser, thereby forming said aerosol inhalable suspension. The process provides particles of optimized particle size and distribution homogeneously dispersed in the carrier, and is also suitable for the preparation of sterile suspensions, includes the step of homogenizing and micronising the formulation in a turboemulsifier provided with a high-potency turbine, optionally followed by a treatment in a high-pressure homogeniser. A process for preparing micronised sterile beclomethasone dipropionate by gamma-irradiation is also disclosed.
Patent NZ-512212-A (NZ)
Title: Uncertainty calculation system and method
Inventor: WILLINK ROBIN DANIEL
IPC: G01F17/00
Filed: 2001-06-06
Abstract: The invention provides a method of calculating uncertainty in the measurement result of a measurement system represented as two or more modules comprising the steps of passing uncertainty information from each module to at least one further module; and calculating uncertainty in the measurement result from the information exchanged between the modules. The invention also provides a method of propagating uncertainty in a measurement system and also provides related systems for calculating uncertainty and propagating uncertainty.
Patent NZ-512506-A (NZ)
Title: Method for removing surface coatings
Inventor: FARROW NIGEL RICHARD
IPC: B24C1/00
Filed: 1999-12-06
Abstract: A method of removing a coating, such as paint, varnish, biological growth or grime from a surface, comprising of selecting a suitable particulate solid having a particular size of 150-250 mm and a fluid carrier heated to 25-50°C, to form a spray mixture and spraying the mixture as a jet spray so as to impact and at least partially remove the coating. The hardness of the particulate solid is less than 8.0 on the Moh scale. An apparatus comprising a blasting pot (1) and a compressor (2) to generate a pressure of 3x105 to 1.5x106 Nm-2 to the spray mixture and propel it from a nozzle (5) is also disclosed.
Patent NZ-512771-A (NZ)
Title: Pharmaceutical composition containing omeprazole in a hydrophobic oily liquid vechicle
Inventor: FREEHAUF KEITH
IPC: A61P1/04
Filed: 2000-02-18
Abstract: An oral pharmaceutical composition comprises: a) 1-60% w/w of omeprazole; b) 0.1-2% w/w of two to four basifying agents such as potassium sorbate or sodium stearate; c) 1-3% w/w or a thickening agent such as hydrogenated castor oil; d) a hydrophobic oily liquid vehicle comprising: i)  a vegetable oil and ii) triglycerides of medium chain fatty acids or propylene glycol diesters of medium chain fatty acids.
Patent NZ-517331-A (NZ)
Title: Human monoclonal antibodies to prostate specific membrane antigen and a transgenic mouse to produce the antibody
Inventor: DEO YASHWANT
IPC: C12N15/85
Filed: 2000-07-26
Abstract: An isolated human monoclonal antibody specifically binds to prostate-specific membrane antigen (PSMA) with an affinity constant of at least about 107M-1. The antibody binds to native human PSMA but not to heat denatured human PSMA, mediates antibody dependant cellular cytotoxicity (ADCC) and is internalized by PSMA-expressing cells. An isolated human monoclonal antibody which specifically binds to human PSMA and mediates cytolysis or inhibits growth of cells expressing human PSMA in the presence of human effector cells and a hybridoma comprising a B cell obtained from a transgenic non-human animal having a genome comprising a human heavy chain transgene and a light chain transgene, fused to a an immortalized cell which produces the antibodies are described. Also described are a method of producing an antibody, bispecific and multispecific molecules comprising the antibodies, methods for detecting the presence of PSMA antigen or a cell expressing PSMA and a nucleic acid encoding the variable region of the antibody. The antibodies can be used in the production of a composition for inhibiting growth of a cell expressing PSMA, for inducing cytolysis of a cell expressing PSMA in the presence of a effector cell and for the treatment or prevention of a disease characterized by aberrant expression of PSMA, preferably the disease is cancer.
Patent NZ-524854-A (NZ)
Title: Method of identifying a receptor, such as a G protein- coupled receptor, which have altered signalling
Inventor: KOPIN ALAN S
IPC: C12Q1/68
Filed: 2001-09-28
Abstract: Methods of identifying receptors having altered signalling are described. Particularly described, an assay for the identification of receptors having alterations in ligand dependent or ligand independent signalling. Receptors having alterations in ligand dependent signalling that can be identified according to the method include hypersensitive hyposensitive receptors and receptors having increased or decreased potency. The method is also applicable to the identification of receptors having alteration in basal activity, for example, constitutively active receptors or receptors having silencing mutations. Further applications include the identification of polymorphic or mutant receptors having alterations in signalling and receptors having an altered drug response. Finally, the receptors identified are useful as tools for drug discovery.
Patent NZ-525817-A (NZ)
Title: Improved treatment
Inventor: RICHARDSON HELENE
IPC: A61K31/535
Filed: 2001-11-12
Abstract: Disclosed herein is the use of two or more intraocular pressure (IOP) reducing agents in combination with capacity of reducing the intraocular pressure in a therapy with an improved efficacy to treat advanced glaucoma in such patients who suffer from detectable vision related impairments, when said agents are administered simultaneously. The combined use will also find advantage in treatment of individuals in need of a high IOP-reduction, such as those being exposed to risk factors rendering them susceptible to visual impairments.
Patent NZ-527439-A (NZ)
Title: A pair of opposed co-operating refining elements
Inventor: VIRVING NILS
IPC: D21D1/30
Filed: 2002-01-29
Abstract: A pair of opposed co-operating refining elements (1, 2) intended for a disc refiner for the disintegration and refining of lignocellulosic material in a refining gap between two opposed counter-rotating refining discs. The refining elements are intended to be placed directly in front of each other on opposed refining discs, and both refining elements (1, 2) are formed with refining surfaces with bars (3, 4) and grooves. In order to prevent generated steam from flowing rearward in the refining gap, a first refining element (1), which is intended for a rotary refining disc, is formed with a first radially restricted zone (7) with elevated bars (8) and a second radially restricted zone (9) without bars directly outside the first zone (7). A second opposed refining element (2) is formed with a third radially restricted zone (10) without bars, which third zone (10) is located directly in front of the first and the second zone (7, 9) on the first refining element (1).
Patent NZ-527472-A (NZ)
Title: 2-Heteroaryl-3,4-dihydro-2H-pyrrole derivatives and the use thereof as pesticides
Inventor: PLANT ANDREW
IPC: A01N43/90
Filed: 2002-01-31
Abstract: Disclosed are delta1-pyrrolines of the formula (I) in which; R1 represents optionally substituted alkyl, or alkoxy or -S(O)wR4, R2 and R3 independently of one another represent hydrogen, halogen or in each case optionally substituted alkyl, alkoxy or alkoxyalkyl, Het represents heteroaryl which is optionally mono- or polysubstituted by identical or different R5. Further disclosed are processes for their preparation, a pesticide preparation comprising them and a method for controlling pests characterized in that compounds of the formula (I) are allowed to act on pests and/or their habitat
Patent NZ-530626-A (NZ)
Title: Test strips for the detection of prion proteins
Inventor: PRICE PAUL
IPC: G01N33/53
Filed: 2002-09-24
Abstract: A test strip of absorbent material for the detection of an analyte in liquid, liquefied, or homogenized samples has a section 11 to be brought in contact with the sample, a first defined region 12 in which detection reagents that specifically bind to a prion protein are immobilized, and a second defined region 13 in which a control reagent that binds to a detection reagent-marker complex present in the sample is immobilized.
Patent NZ-532223-A (NZ)
Title: Juice extractor
Inventor: EVANS KEVIN E
IPC: A23N1/00
Filed: 2001-09-14
Abstract: An extractor (not shown) is disclosed for separating the juice and juice sacs from a citrus fruit that includes a lower cup for supporting a single piece of citrus fruit and an upper cup disposed vertically above the lower cup with the upper and lower cups moveable relative to each other in a vertical direction so as to cooperate to squeeze the piece of citrus fruit placed therebetween. An upper cutter is provided for cutting a plug in the citrus to permit the separation of the peel from the juice and the juice sacs, while a lower cutter is provided for cutting the plug to allow the juice and juice sacs to exit therethrough when the fruit is squeezed between the upper and lower cups. A strainer tube (26) is vertically oriented beneath the lower cup and lower cutter, with the strainer tube having a plurality of circumferential slots (38) along its working length (36). A plunger tube is slidingly received within the strainer tube for forcing the juice and juice sacs outwardly through the slots and the strainer tube into a separate reservoir. The slots in the strainer tube may be of equal width and evenly spaced apart or of varying widths. In any event, the slots are preferably between about 0.5 and about 3 millimeters in width.
Patent NZ-534472-A (NZ)
Title: Sound dampened sink
Inventor: DE CLEENE CHRISTOPHER M
IPC: E03C1/18
Filed: 2003-01-31
Abstract: A sink (10), and a method of reducing vibration and resulting noise of such sinks, are disclosed. The sink includes a basin (20), a drain (8), and first and second pads (32, 48). The basin has a bottom wall (12), side walls (22, 24, 26, 28), and inner and outer surfaces (16, 18) of such walls. The drain is in the bottom of the basin, and first and second regions are defined between the drain orifice and the first and second sides, respectively. The pads are attached to the bottom and a side wall, in each case proximate respective mid-points of open regions thereon. The pads are laminate of a rubber-like material and metal.
Patent NZ-540845-A (NZ)
Title: Optically active dihydropyridine derivative
Inventor: KOBAYASHI TAKASHI
IPC: A61P43/00
Filed: 2003-12-24
Abstract: Disclosed is An optically active dihydropyridine derivative R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidine-3-yl)ester 5-isopropylester or a pharmaceutically acceptable salt thereof having superior blood pressure lowering action, cardiac protective action, and a therapeutic agent or preventive agent comprising the same for hypertension, heart diseases, arteriosclerosis and kidney disorders.
Patent NZ-545440-A (NZ)
Title: Meldonium salts, method of their preparation and pharmaceutical compositions on their basis
Inventor: KALVINSH IVARS
IPC: A61K31/205
Filed: 2004-07-15
Abstract: Meldonium salts of formula: X-(CH3)3N+NHCH2CH2COOH wherein X- is an acid anion selected from the group consisting of dihydrogen phosphate, hydrogen fumarate and orotate anions, the method of their preparation, and pharmaceutical formulation on their basis have been disclosed. These Meldonium salts are non-hygroscopic and they have an increased thermal stability and a lasting action. Pharmaceutical formulations containing non-hygroscopic and/or increased thermal stability and/or lasting action 3-(2,2,2-trimethylhydrazinium) propionate salts for oral, parenteral, rectal and transdermal introduction are concurrently described. The disclosed process for producing the meldonium salts includes the steps: (a) dissolving in a manner known per se meldonium having the formula 3-(2,2,2-trimethylhydrazinium) propionate in water or any other appropriate solvent; (b) adding an equimolar quantity of a polybasic acid selected from the group consisting of fumaric acid, phosphoric acid, and erotic acid; (c) stirring the mixture at a temperature of from 20 to 50 Deg. C until the corresponding salt is formed; and (d) evaporating the meldonium salt formed in step (c) to dryness, if necessary; and optionally recrystallising it from a suitable solvent.
Patent NZ-548039-A (NZ)
Title: Apparatus for concealing a product such as a video projector by moving a hinged panel
Inventor: TRANTER NATHAN ARTHUR
IPC: A47B17/04
Filed: 2004-11-25
Abstract: A desktop apparatus (6) for concealing an item (34) is disclosed. The item is housed within a cavity and mounted in such a way as to be concealed in one position and available for use in another. The apparatus (6) comprises a frame (14) with an opening with is mountable in the cavity or around the periphery of the cavity and adapted to fit to a desktop (36). A four sided panel (28) is movable within the frame (14) and use for mounting the item (34). A pivot rod (22) attached to the panel rotates in a bush (18) formed in corresponding sides of the frame (14). This connects the panel (28) to the frame (14) to enable movement of the panel (28) between the first and second position. The pivot assembly (18, 22) is located adjacent an opening to the cavity such that in the first position the product and apparatus are substantially concealed from view and in the second position the product is in view and physically accessible by a user from the desktop. The panel (28) substantially covers an opening through the frame (14) in the first and second positions.
Patent NZ-548434-A (NZ)
Title: Mooring arrangement provided with floating mobile systems for moving booms
Inventor: BERNADAC JEAN-CLAUDE
IPC: E02B3/06
Filed: 2004-12-13
Abstract: Disclosed is the arrangement of motorised floating mobile systems (7, 107, 207) for moving mooring booms (4a to 4e) for boats (B) and crafts in an inner harbours (P) in order to translationally move said booms (4a to 4e) along a trajectory perpendicular thereto in such a way that a manoeuvring space for the boats (B) and crafts is arranged between at least two adjacent booms (4, 4a to 4e), whereas the other spaces between booms are closed for manoeuvring. Each system comprises means for fixing booms or the sections thereof (5), which are disposed in a perpendicular direction to the translation direction, means (9, 10) which are arranged on the two ends of the system and enables said system to be attached to an identical system in the front thereof or to attaching means arranged on the end of a platform or the fixed boom, means for translationally guiding in a direction parallel to a berth or a main hulk with respect to a fixed bridge formed by a post or a berth (8) or a group of posts or berths driven into the bottom of the harbour and means which translationally moves the booms and are controlled by means for synchronously controlling said manoeuvres.